Beta Drugs Limited

BETANSE · IN

Holders

Ashish Kacholia
Investor
—
5,43,800 sh
as-of 30 Jun 2026Quarterly

Ownership

FIIs trimmed their stake −1.9pp QoQ

Jun 2026 quarter

Upgrade to see this quarter’s exact figures

Ownership by quarter

Promoter

— −5.5pp

67.558.5

FII

— +1.8pp

3.50.5

DII

— +3.9pp

Disclosure timeline

DISCLOSEDQuarterly
Ashish Kacholia
Beta Drugs Limited · NSE
5,43,800 sh
Filed 17 Jul 2026NSE shareholding patternview source
DISCLOSEDQuarterly
Ashish Kacholia
Beta Drugs Limited · NSE
5,79,097 sh
Filed 11 Jun 2026NSE shareholding patternview source
DISCLOSEDQuarterly
Ashish Kacholia
Beta Drugs Limited · NSE
5,83,800 sh
Filed 6 Apr 2026NSE shareholding patternview source
DISCLOSEDStale
Ashish Kacholia
Beta Drugs Limited · NSE
5,83,800 sh
Filed 13 Jan 2026NSE shareholding patternview source
REDUCEDStale
Neeraj Batra
Beta Drugs Limited · NSE
−1,85,115 sh · ₹31.21 Cr
Filed 13 Nov 2025SEBI Reg 7view source
DISCLOSEDStale
Ashish Kacholia
Beta Drugs Limited · NSE
5,83,800 sh
Filed 13 Oct 2025NSE shareholding patternview source
DISCLOSEDStale
Ashish Kacholia
Beta Drugs Limited · NSE
5,83,800 sh
Filed 9 Jul 2025NSE shareholding patternview source

Announcements

The announcements library is part of Pro.

Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.

3 announcements on record for this company.

Part of Pro — upgrade to open